An ultrasensitive UPLC-MS/MS assay for the quantification of the therapeutic peptide liraglutide in plasma to assess the oral and nasal bioavailability in beagle dogs

Aim: An ultrasensitive UPLC-MS/MS assay for liraglutide was developed and validated according to US FDA and EMA guidelines and applied to the quantification of plasma concentrations after intravenous, nasal and oral administration of liraglutide to beagle dogs. Results: Liraglutide isolation was per...

Full description

Saved in:
Bibliographic Details
Main Authors: Sauter, Max (Author) , Uhl, Philipp (Author) , Majewsky, Marius (Author) , Fresnais, Margaux (Author) , Haefeli, Walter E. (Author) , Burhenne, Jürgen (Author)
Format: Article (Journal)
Language:English
Published: 16 May 2019
In: Bioanalysis
Year: 2019, Volume: 11, Issue: 9, Pages: 887-898
ISSN:1757-6199
DOI:10.4155/bio-2018-0322
Online Access:Verlag, Volltext: https://doi.org/10.4155/bio-2018-0322
Verlag, Volltext: https://www.future-science.com/doi/10.4155/bio-2018-0322
Get full text
Author Notes:Max Sauter, Philipp Uhl, Marius Majewsky, Margaux Fresnais, Walter E Haefeli and Jürgen Burhenne

MARC

LEADER 00000caa a2200000 c 4500
001 1680017667
003 DE-627
005 20240323101410.0
007 cr uuu---uuuuu
008 191025s2019 xx |||||o 00| ||eng c
024 7 |a 10.4155/bio-2018-0322  |2 doi 
035 |a (DE-627)1680017667 
035 |a (DE-599)KXP1680017667 
035 |a (OCoLC)1341249240 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sauter, Max  |e VerfasserIn  |0 (DE-588)1103516507  |0 (DE-627)86126813X  |0 (DE-576)470642033  |4 aut 
245 1 3 |a An ultrasensitive UPLC-MS/MS assay for the quantification of the therapeutic peptide liraglutide in plasma to assess the oral and nasal bioavailability in beagle dogs  |c Max Sauter, Philipp Uhl, Marius Majewsky, Margaux Fresnais, Walter E Haefeli and Jürgen Burhenne 
264 1 |c 16 May 2019 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.10.2019 
520 |a Aim: An ultrasensitive UPLC-MS/MS assay for liraglutide was developed and validated according to US FDA and EMA guidelines and applied to the quantification of plasma concentrations after intravenous, nasal and oral administration of liraglutide to beagle dogs. Results: Liraglutide isolation was performed with a combined protein precipitation and solid-phase extraction protocol. The calibrated concentration range of 0.1-200 ng/ml was linear with correlation coefficients >0.998. Precise analysis was achieved through the utilization of an isotopically labeled internal standard. Absolute bioavailability of liraglutide after nasal and oral administration of liraglutide to beagle dogs was 0.03 and 0.006%, respectively. Conclusion: The assay matches the performance in sensitivity of the previously applied immunoassay and optimally covers the therapeutic range of liraglutide. 
700 1 |a Uhl, Philipp  |e VerfasserIn  |0 (DE-588)1112349391  |0 (DE-627)866420797  |0 (DE-576)476575230  |4 aut 
700 1 |a Majewsky, Marius  |d 1980-  |e VerfasserIn  |0 (DE-588)1021321494  |0 (DE-627)689775679  |0 (DE-576)362987602  |4 aut 
700 1 |a Fresnais, Margaux  |e VerfasserIn  |0 (DE-588)1190043157  |0 (DE-627)1668720108  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
700 1 |a Burhenne, Jürgen  |d 1963-  |e VerfasserIn  |0 (DE-588)1034228889  |0 (DE-627)745126987  |0 (DE-576)381858197  |4 aut 
773 0 8 |i Enthalten in  |t Bioanalysis  |d London : Future Science, 2009  |g 11(2019), 9, Seite 887-898  |h Online-Ressource  |w (DE-627)634477854  |w (DE-600)2571813-7  |w (DE-576)398101434  |x 1757-6199  |7 nnas  |a An ultrasensitive UPLC-MS/MS assay for the quantification of the therapeutic peptide liraglutide in plasma to assess the oral and nasal bioavailability in beagle dogs 
773 1 8 |g volume:11  |g year:2019  |g number:9  |g pages:887-898  |g extent:12  |a An ultrasensitive UPLC-MS/MS assay for the quantification of the therapeutic peptide liraglutide in plasma to assess the oral and nasal bioavailability in beagle dogs 
856 4 0 |u https://doi.org/10.4155/bio-2018-0322  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.future-science.com/doi/10.4155/bio-2018-0322  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20191025 
993 |a Article 
994 |a 2019 
998 |g 1034228889  |a Burhenne, Jürgen  |m 1034228889:Burhenne, Jürgen  |d 910000  |d 910100  |e 910000PB1034228889  |e 910100PB1034228889  |k 0/910000/  |k 1/910000/910100/  |p 6  |y j 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 1190043157  |a Fresnais, Margaux  |m 1190043157:Fresnais, Margaux  |p 4 
998 |g 1021321494  |a Majewsky, Marius  |m 1021321494:Majewsky, Marius  |d 910000  |d 910100  |e 910000PM1021321494  |e 910100PM1021321494  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1112349391  |a Uhl, Philipp  |m 1112349391:Uhl, Philipp  |d 910000  |d 910100  |e 910000PU1112349391  |e 910100PU1112349391  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1103516507  |a Sauter, Max  |m 1103516507:Sauter, Max  |d 910000  |d 910100  |e 910000PS1103516507  |e 910100PS1103516507  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1680017667  |e 3527310991 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title_sort":"Bioanalysis","title":"Bioanalysis"}],"pubHistory":["1.2009 -"],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 30.05.24"],"part":{"year":"2019","issue":"9","pages":"887-898","volume":"11","text":"11(2019), 9, Seite 887-898","extent":"12"},"id":{"eki":["634477854"],"issn":["1757-6199"],"zdb":["2571813-7"]},"origin":[{"dateIssuedDisp":"2009-","publisher":"Future Science","dateIssuedKey":"2009","publisherPlace":"London"}],"disp":"An ultrasensitive UPLC-MS/MS assay for the quantification of the therapeutic peptide liraglutide in plasma to assess the oral and nasal bioavailability in beagle dogsBioanalysis","recId":"634477854"}],"note":["Gesehen am 25.10.2019"],"id":{"doi":["10.4155/bio-2018-0322"],"eki":["1680017667"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"16 May 2019"}],"name":{"displayForm":["Max Sauter, Philipp Uhl, Marius Majewsky, Margaux Fresnais, Walter E Haefeli and Jürgen Burhenne"]},"recId":"1680017667","person":[{"display":"Sauter, Max","family":"Sauter","given":"Max","role":"aut"},{"family":"Uhl","role":"aut","given":"Philipp","display":"Uhl, Philipp"},{"family":"Majewsky","given":"Marius","role":"aut","display":"Majewsky, Marius"},{"role":"aut","given":"Margaux","family":"Fresnais","display":"Fresnais, Margaux"},{"role":"aut","given":"Walter E.","family":"Haefeli","display":"Haefeli, Walter E."},{"family":"Burhenne","given":"Jürgen","role":"aut","display":"Burhenne, Jürgen"}],"title":[{"title_sort":"ultrasensitive UPLC-MS/MS assay for the quantification of the therapeutic peptide liraglutide in plasma to assess the oral and nasal bioavailability in beagle dogs","title":"An ultrasensitive UPLC-MS/MS assay for the quantification of the therapeutic peptide liraglutide in plasma to assess the oral and nasal bioavailability in beagle dogs"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"12 S."}],"language":["eng"]} 
SRT |a SAUTERMAXUULTRASENSI1620